Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunodeficiency Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00035893
What this trial is testing

The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART

Who this might be right for
HIV SeropositivityHIV Infection
AIM ImmunoTech Inc. 40
Not applicableStudy completedNCT05084716
What this trial is testing

Pre-Exposure Prophylaxis (PrEP) Provision for Ugandan Fisherfolk

Who this might be right for
HIV
RAND 885
Large-scale testing (Phase 3)Study completedNCT01458171
What this trial is testing

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency Disorder
CSL Behring 23
Large-scale testing (Phase 3)Study completedNCT04180163
What this trial is testing

Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 12
Testing effectiveness (Phase 2)Study completedNCT00008463
What this trial is testing

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 132
Early research (Phase 1)Study completedNCT00001133
What this trial is testing

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT01020552
What this trial is testing

Integrating Family Planning Into Postabortion Care

Who this might be right for
Postabortion Care
FHI 360 300
Not applicableStudy completedNCT03408106
What this trial is testing

Prospective Clinical Trial of HIV+ Living Donor Kidney Donation for HIV+ Recipients

Who this might be right for
HIV Infections
Johns Hopkins University 3
Not applicableStudy completedNCT01716299
What this trial is testing

Comparison of HIV Testing Algorithms

Who this might be right for
HIV Infection
Medecins Sans Frontieres, Netherlands 495
Not applicableStudy completedNCT00002398
What this trial is testing

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Gilead Sciences
Not applicableStudy completedNCT00440206
What this trial is testing

Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes

Who this might be right for
HIV Infections
Ottawa Hospital Research Institute 50
Not applicableStudy completedNCT00067704
What this trial is testing

Emotional Disclosure in HIV

Who this might be right for
HIV Infections
University of Miami 283
Not applicableStudy completedNCT03451032
What this trial is testing

Regional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIV

Who this might be right for
Hiv
Nantes University Hospital 150
Early research (Phase 1)Study completedNCT05204121
What this trial is testing

Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers

Who this might be right for
HIV Infections
Viriom 36
Early research (Phase 1)Study completedNCT00124007
What this trial is testing

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Not applicableStudy completedNCT03868644
What this trial is testing

The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya

Who this might be right for
HIV/AIDSHSV-2 Infection
Abdul Latif Jameel Poverty Action Lab 10,646
Early research (Phase 1)Study completedNCT00058734
What this trial is testing

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 5
Post-approval studies (Phase 4)Study completedNCT00718536
What this trial is testing

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 15
Not applicableLooking for participantsNCT07111598
What this trial is testing

Immunological Effects of Iron Supplementation in HHT Disease

Who this might be right for
Hereditary Haemorrhagic Telangiectasia
Hospices Civils de Lyon 155
Not applicableUnknownNCT05225493
What this trial is testing

HIV Indicator Diseases in Hospital and Primary Care

Who this might be right for
HIV InfectionsPrimary Health CareAcquired Immunodeficiency Syndrome+15 more
Erasmus Medical Center 1,500
Next Page